elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33756924-77613C67-DF5C-4C75-914D-9B9A9FE886F5
Q33756924-77613C67-DF5C-4C75-914D-9B9A9FE886F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33756924-77613C67-DF5C-4C75-914D-9B9A9FE886F5
Patient's perspectives important for early anti-tumor necrosis factor treatment in inflammatory bowel disease.
P2860
Q33756924-77613C67-DF5C-4C75-914D-9B9A9FE886F5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33756924-77613C67-DF5C-4C75-914D-9B9A9FE886F5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c3e35cf731bfca8f2dcfb77245a3a1dbc0a9b262
P2860
Risks and benefits of infliximab for the treatment of Crohn's disease